KRTL BioTech

Facebook upgraded by Moffett Nathanson, which says regulatory risk is priced in, but growth is not

Facebook upgraded by Moffett Nathanson, which says regulatory risk is priced in, but growth is not

The core health of Facebook's business outweighs worries about regulatory scrutiny, according to Moffett Nathanson.